All In Biotech

Drug Trial Radar · NCT05343260

Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery

Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on 5-year Survival in Elderly Patients After Cancer Surgery: a Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jul 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,228 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,228

Actual

Start

Apr 1, 2015

Primary completion

Sep 30, 2022

Study completion Mar 30, 2023

Sponsor

Lead sponsor
Peking University First HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 65 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Surgery is one of the major treatment methods for patients with solid organ cancer. And, alone with the ageing process, more and more elderly patients undergo surgery for cancer. Evidence emerges that choice of anesthetics, i.e., either inhalational or intravenous anesthetics, may influence the outcome of elderly patients undergoing cancer surgery. From the point of view of immune function after surgery and invasiveness of malignant tumor cells, propofol intravenous anesthesia may be superior to inhalational anesthesia. However, the clinical significance of these effects remains unclear. Retrospective studies indicated that use of propofol intravenous anesthesia was associated higher long-term survival rate. Prospective studies exploring the effect of anesthetic choice on long-term survival in cancer surgery patients are urgently needed.

Conditions

  • Aged
  • Neoplasms
  • Surgical Procedure, Operative
  • Anesthesia, Inhalation
  • Anesthesia, Intravenous
  • Survival

Interventions

  • SevofluraneDrug

    Sevoflurane will be administered by inhalation for anesthesia maintenance. The concentration of inhaled sevoflurane will be adjusted to maintain the BIS value between 40 and 60. Sevoflurane inhalational concentration will be decreased towards the end of surgery. Sevoflurane inhalation will be stopped at the end of surgery.

  • PropofolDrug

    Propofol will be administered by intravenous infusion for anesthesia maintenance. The infusion rate of propofol will be adjusted to maintain the BIS value between 40 and 60. Propofol infusion rate will be decreased towards the end of surgery. Propofol infusion will be stopped at the end of surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Over survival after surgery.Time frame: Up to 5 years after surgery

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Tianjin Nankai Hospital

    Tianjin, China

  • Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital

    Beijing, Beijing Municipality, China

  • Beijing Shijitan Hospital

    Beijing, Beijing Municipality, China

  • Peking University Cancer Hospital

    Beijing, Beijing Municipality, China

  • Cancer Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China

  • Hebei Medical University Forth Hospital

    Shijiazhuang, Hebei, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhenzhou, Henan, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Zhongda Hospital

    Nanjing, Jiangsu, China

  • Ningxia People's Hospital

    Yinchuan, Ningxia, China

  • Affiliated Hospital of Qinghai University

    Xining, Qinghai, China

  • Tang-Du Hospital

    Xi'an, Shaanxi, China

  • Shaanxi Provincial People's Hospital

    Taiyuan, Shanxi, China

  • Shanxi Province Cancer Hospital

    Taiyuan, Shanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.